Status:
UNKNOWN
Fructose Effect on Neuroinflammation and Feelings
Lead Sponsor:
University Hospital, Rouen
Conditions:
Gastro-Intestinal Disorder
Eligibility:
MALE
18-35 years
Phase:
NA
Brief Summary
Fructose is increasingly present in our food. The increase in its consumption is associated with the increase in the prevalence of several pathologies such as metabolic syndrome or hepatic steatosis. ...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Aged 18 to 35
- Male sex
- BMI between 18.5 and 25
- Affiliation to a social security scheme
- Adult patient having read and understood the information letter and signed the consent form
Exclusion
- Presence of irritable bowel syndrome, celiac disease
- Presence of a psychiatric illness
- Presence of a neurodegenerative disease
- Presence of an eating disorder
- Presence of chronic disease, including inflammatory disease
- Presence of diabetes
- Presence of an acute infectious disease
- Presence of a surgical history of the digestive tract (excluding appendectomy)
- Taking long-term treatment
- Taking antibiotics within 6 months
- Taking probiotics within 3 months
- Typical diet low in lactose, FODMAP, gluten, vegetarian, vegan, vegan, chromonutrition .... in progress
- Smoker
- Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection / under guardianship or guardianship
- Simultaneous participation in another interventional clinical trial
Key Trial Info
Start Date :
June 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 8 2022
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT05371067
Start Date
June 8 2021
End Date
August 8 2022
Last Update
May 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de ROUEN
Rouen, France, 76000